Variant report
Variant | esv3385679 |
---|---|
Chromosome Location | chr8:58105348-58107846 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:42)
- CpG islands (count:244)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:42 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr8:58105853-58106191 | K562 | blood: | n/a | n/a |
2 | CBX3 | chr8:58105849-58106177 | K562 | blood: | n/a | n/a |
3 | CCNT2 | chr8:58105900-58106102 | K562 | blood: | n/a | n/a |
4 | CHD2 | chr8:58105531-58106370 | K562 | blood: | n/a | n/a |
5 | CTCF | chr8:58105992-58106227 | K562 | blood: | n/a | chr8:58106108-58106121 |
6 | CTCFL | chr8:58106011-58106160 | K562 | blood: | n/a | chr8:58106112-58106121 |
7 | CTCFL | chr8:58105985-58106146 | K562 | blood: | n/a | chr8:58106112-58106121 |
8 | E2F6 | chr8:58105858-58106232 | K562 | blood: | n/a | chr8:58106105-58106115 chr8:58106133-58106142 |
9 | E2F6 | chr8:58105733-58106515 | K562 | blood: | n/a | chr8:58106433-58106442 chr8:58106105-58106115 chr8:58106133-58106142 chr8:58106435-58106444 |
10 | E2F6 | chr8:58105949-58106146 | K562 | blood: | n/a | chr8:58106105-58106115 chr8:58106133-58106142 |
11 | EGR1 | chr8:58105941-58106208 | K562 | blood: | n/a | chr8:58106133-58106142 |
12 | EGR1 | chr8:58106002-58106255 | K562 | blood: | n/a | chr8:58106133-58106142 |
13 | ELF1 | chr8:58105894-58106150 | K562 | blood: | n/a | n/a |
14 | ETS1 | chr8:58105886-58106248 | GM12878 | blood: | n/a | n/a |
15 | GTF2F1 | chr8:58106004-58106115 | K562 | blood: | n/a | n/a |
16 | HCFC1 | chr8:58105853-58106256 | K562 | blood: | n/a | n/a |
17 | HEY1 | chr8:58105799-58106263 | K562 | blood: | n/a | n/a |
18 | HMGN3 | chr8:58105784-58106166 | K562 | blood: | n/a | n/a |
19 | IRF1 | chr8:58106045-58106192 | K562 | blood: | n/a | n/a |
20 | JUND | chr8:58105872-58106546 | K562 | blood: | n/a | chr8:58106434-58106443 |
21 | MAFF | chr8:58105979-58106221 | K562 | blood: | n/a | n/a |
22 | MAX | chr8:58105768-58106293 | K562 | blood: | n/a | chr8:58106034-58106044 chr8:58106035-58106044 chr8:58106036-58106043 chr8:58106034-58106044 chr8:58106035-58106044 |
23 | MAX | chr8:58105825-58106262 | K562 | blood: | n/a | chr8:58106034-58106044 chr8:58106035-58106044 chr8:58106036-58106043 chr8:58106034-58106044 chr8:58106035-58106044 |
24 | MAX | chr8:58105922-58106175 | K562 | blood: | n/a | chr8:58106034-58106044 chr8:58106035-58106044 chr8:58106036-58106043 chr8:58106034-58106044 chr8:58106035-58106044 |
25 | MAZ | chr8:58105673-58106399 | K562 | blood: | n/a | chr8:58106034-58106044 chr8:58106035-58106044 chr8:58106036-58106043 chr8:58106034-58106044 chr8:58106035-58106044 |
26 | MYC | chr8:58105759-58106491 | K562 | blood: | n/a | chr8:58106034-58106044 chr8:58106035-58106044 chr8:58106036-58106043 chr8:58106034-58106044 chr8:58106035-58106044 |
27 | MYC | chr8:58105677-58106296 | K562 | blood: | n/a | chr8:58106034-58106044 chr8:58106035-58106044 chr8:58106036-58106043 chr8:58106034-58106044 chr8:58106035-58106044 |
28 | MYC | chr8:58106074-58106128 | K562 | blood: | n/a | n/a |
29 | NRF1 | chr8:58105956-58106285 | K562 | blood: | n/a | chr8:58106129-58106143 chr8:58106132-58106141 chr8:58106134-58106143 chr8:58106101-58106112 chr8:58106132-58106146 chr8:58106131-58106142 chr8:58106132-58106143 |
30 | POLR2A | chr8:58105766-58105770 | K562 | blood: | n/a | n/a |
31 | POLR2A | chr8:58105774-58106563 | K562 | blood: | n/a | n/a |
32 | POLR2A | chr8:58106049-58106300 | K562 | blood: | n/a | n/a |
33 | POLR2A | chr8:58106746-58106752 | K562 | blood: | n/a | n/a |
34 | POLR2A | chr8:58105877-58106270 | K562 | blood: | n/a | n/a |
35 | POLR2A | chr8:58105826-58106574 | K562 | blood: | n/a | n/a |
36 | POLR2A | chr8:58105840-58106520 | K562 | blood: | n/a | n/a |
37 | RCOR1 | chr8:58105914-58106205 | K562 | blood: | n/a | n/a |
38 | TBP | chr8:58105980-58106247 | K562 | blood: | n/a | n/a |
39 | USF1 | chr8:58105826-58106274 | K562 | blood: | n/a | n/a |
40 | YY1 | chr8:58105949-58106175 | K562 | blood: | n/a | chr8:58105970-58105981 |
41 | ZBTB33 | chr8:58105860-58106248 | K562 | blood: | n/a | chr8:58106099-58106109 |
42 | ZBTB33 | chr8:58105806-58106242 | K562 | blood: | n/a | chr8:58106099-58106109 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:58106598-58106648 | T-47D | breast: | n/a |
2 | chr8:58106155-58106205 | HIPEpiC | eye: | n/a |
3 | chr8:58106155-58106205 | Hepatocyte | liver: | n/a |
4 | chr8:58106155-58106205 | PFSK-1 | brain: | n/a |
5 | chr8:58106598-58106648 | HNPCEpiC | eye: | n/a |
6 | chr8:58106520-58106570 | U87 | brain: | n/a |
7 | chr8:58106155-58106205 | MCF10A-Er-Src | breast: | n/a |
8 | chr8:58106520-58106570 | GM12878 | blood: | n/a |
9 | chr8:58106520-58106570 | AG09309 | skin: | n/a |
10 | chr8:58106155-58106205 | BE2_C | brain: | n/a |
11 | chr8:58106155-58106205 | SKMC | muscle: | n/a |
12 | chr8:58106598-58106648 | HCM | heart: | n/a |
13 | chr8:58106155-58106205 | HPAEpiC | pulmonary alveolar: | n/a |
14 | chr8:58106598-58106648 | AG10803 | skin: | n/a |
15 | chr8:58106155-58106205 | U87 | brain: | n/a |
16 | chr8:58106155-58106205 | AG09309 | skin: | n/a |
17 | chr8:58106598-58106648 | HRPEpiC | eye: | n/a |
18 | chr8:58106155-58106205 | HUVEC | blood vessel: | n/a |
19 | chr8:58106094-58106144 | PFSK-1 | brain: | n/a |
20 | chr8:58106598-58106648 | HepG2 | liver: | n/a |
21 | chr8:58106520-58106570 | NHBE | bronchial: | n/a |
22 | chr8:58106520-58106570 | PrEC | prostate: | n/a |
23 | chr8:58106094-58106144 | SK-N-MC | brain: | n/a |
24 | chr8:58106155-58106205 | HEK293 | kidney: | embryo |
25 | chr8:58106155-58106205 | ovcar-3 | ovarian: | n/a |
26 | chr8:58106598-58106648 | MCF-7 | breast: | n/a |
27 | chr8:58106520-58106570 | HMEC | breast: | n/a |
28 | chr8:58106094-58106144 | HMEC | breast: | n/a |
29 | chr8:58106155-58106205 | HRE | kidney: | n/a |
30 | chr8:58106155-58106205 | BJ | skin: | n/a |
31 | chr8:58106520-58106570 | HCM | heart: | n/a |
32 | chr8:58106598-58106648 | HMEC | breast: | n/a |
33 | chr8:58106094-58106144 | HUVEC | blood vessel: | n/a |
34 | chr8:58106520-58106570 | AG04449 | skin: | fetal |
35 | chr8:58106155-58106205 | MCF-7 | breast: | n/a |
36 | chr8:58106598-58106648 | ovcar-3 | ovarian: | n/a |
37 | chr8:58106094-58106144 | HL-60 | blood: | n/a |
38 | chr8:58106155-58106205 | SAEC | small airway: | n/a |
39 | chr8:58106094-58106144 | HepG2 | liver: | n/a |
40 | chr8:58106155-58106205 | GM19239 | blood: | n/a |
41 | chr8:58106155-58106205 | SK-N-SH_RA | brain: | n/a |
42 | chr8:58106520-58106570 | BJ | skin: | n/a |
43 | chr8:58106155-58106205 | Hela-S3 | cervix: | n/a |
44 | chr8:58106598-58106648 | AG04449 | skin: | fetal |
45 | chr8:58106520-58106570 | HNPCEpiC | eye: | n/a |
46 | chr8:58106520-58106570 | ECC-1 | luminal epithelium: | n/a |
47 | chr8:58106155-58106205 | LNCaP | prostate: | n/a |
48 | chr8:58106520-58106570 | GM19239 | blood: | n/a |
49 | chr8:58106094-58106144 | NT2-D1 | testis: | n/a |
50 | chr8:58106094-58106144 | SAEC | small airway: | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM110B-8 | chr8:58106444-58106570 | ENSG00000253301.1 |
2 | lnc-FAM110B-8 | chr8:58106179-58106275 | ENSG00000253301.1 |
3 | lnc-FAM110B-8 | chr8:58106444-58106570 | ENSG00000253301.1 |
4 | lnc-FAM110B-8 | chr8:58106149-58106248 | ENSG00000253301.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000253301 | TF binding region |
ENSG00000253301 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560467571 | chr8:58105403-58105404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532296317 | chr8:58105404-58105405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552444331 | chr8:58105422-58105423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565372933 | chr8:58105604-58105605 | Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs189821082 | chr8:58105605-58105606 | Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs17194529 | chr8:58105647-58105648 | Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs142751797 | chr8:58105716-58105717 | Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs66477547 | chr8:58105763-58105764 | Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs375741838 | chr8:58105767-58105768 | Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs566827670 | chr8:58105778-58105779 | Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs182147706 | chr8:58105781-58105782 | Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs558919617 | chr8:58105784-58105785 | Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs75644437 | chr8:58105793-58105794 | Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs371059090 | chr8:58105795-58105796 | Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs537514371 | chr8:58105797-58105798 | Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs574321511 | chr8:58105814-58105815 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs386725758 | chr8:58105856-58105857 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs56066782 | chr8:58105857-58105858 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs17802743 | chr8:58105897-58105898 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs375832982 | chr8:58105908-58105909 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs564968880 | chr8:58105926-58105927 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs528529809 | chr8:58105927-58105928 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs577247221 | chr8:58105944-58105945 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs55955962 | chr8:58105952-58105953 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs397933649 | chr8:58105953-58105954 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs16921807 | chr8:58105967-58105968 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs372853258 | chr8:58105993-58105994 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs56235637 | chr8:58106008-58106009 | Enhancers Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs117008184 | chr8:58106023-58106024 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs77494377 | chr8:58106030-58106031 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs529991664 | chr8:58106036-58106037 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs16921808 | chr8:58106049-58106050 | Enhancers Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs566815342 | chr8:58106051-58106052 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs532694050 | chr8:58106056-58106057 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs16921810 | chr8:58106067-58106068 | Enhancers Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs569316350 | chr8:58106070-58106071 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs567034099 | chr8:58106071-58106072 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs538441625 | chr8:58106095-58106096 | Enhancers Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs532874963 | chr8:58106111-58106112 | Enhancers Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs554318611 | chr8:58106114-58106115 | Enhancers Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs568206283 | chr8:58106118-58106119 | Enhancers Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs533758045 | chr8:58106141-58106142 | Enhancers Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs372984165 | chr8:58106152-58106153 | Enhancers Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs375583280 | chr8:58106167-58106168 | Enhancers Active TSS | TF binding regionCpG islandlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs577191318 | chr8:58106174-58106175 | Enhancers Active TSS | TF binding regionCpG islandlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs545753492 | chr8:58106182-58106183 | Enhancers Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs556439516 | chr8:58106193-58106194 | Enhancers Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs13253625 | chr8:58106206-58106207 | Weak transcription Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs16920056 | chr8:58106218-58106219 | Weak transcription Active TSS | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs373501573 | chr8:58106230-58106231 | Weak transcription Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 22183965 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:58105400-58105600 | Enhancers | K562 | blood |
2 | chr8:58105600-58106000 | Flanking Active TSS | K562 | blood |
3 | chr8:58105800-58106000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr8:58106000-58106200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr8:58106000-58107200 | Active TSS | K562 | blood |
6 | chr8:58106200-58114800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |